A citation-based method for searching scientific literature

Hye-Joung Eom, Joo Hee Cha, Woo Jung Choi, Eun Young Chae, Hee Jung Shin, Hak Hee Kim. AJR Am J Roentgenol 2017
Times Cited: 24







List of co-cited articles
208 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
41

Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer.
Eren Yeh, Priscilla Slanetz, Daniel B Kopans, Elizabeth Rafferty, Dianne Georgian-Smith, Linda Moy, Elkan Halpern, Richard Moore, Irene Kuter, Alphonse Taghian. AJR Am J Roentgenol 2005
246
29


Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
Gunter von Minckwitz, Michael Untch, Jens-Uwe Blohmer, Serban D Costa, Holger Eidtmann, Peter A Fasching, Bernd Gerber, Wolfgang Eiermann, Jörn Hilfrich, Jens Huober,[...]. J Clin Oncol 2012
25

MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.
Briete Goorts, Kelly M A Dreuning, Janneke B Houwers, Loes F S Kooreman, Evert-Jan G Boerma, Ritse M Mann, Marc B I Lobbes, Marjolein L Smidt. Breast Cancer Res 2018
28
25

Multi-parametric MRI in the early prediction of response to neo-adjuvant chemotherapy in breast cancer: Value of non-modelled parameters.
Elizabeth A M O'Flynn, David Collins, James D'Arcy, Maria Schmidt, Nandita M de Souza. Eur J Radiol 2016
31
20


Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
Jennifer F De Los Santos, Alan Cantor, Keith D Amos, Andres Forero, Mehra Golshan, Janet K Horton, Clifford A Hudis, Nola M Hylton, Kandace McGuire, Funda Meric-Bernstam,[...]. Cancer 2013
132
20


Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
Nola M Hylton, Jeffrey D Blume, Wanda K Bernreuter, Etta D Pisano, Mark A Rosen, Elizabeth A Morris, Paul T Weatherall, Constance D Lehman, Gillian M Newstead, Sandra Polin,[...]. Radiology 2012
288
20

Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.
Claudette E Loo, Marieke E Straver, Sjoerd Rodenhuis, Sara H Muller, Jelle Wesseling, Marie-Jeanne T F D Vrancken Peeters, Kenneth G A Gilhuijs. J Clin Oncol 2011
190
20

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer.
Ippei Fukada, Kazuhiro Araki, Kokoro Kobayashi, Tomoko Shibayama, Shunji Takahashi, Naoya Gomi, Yumi Kokubu, Katsunori Oikado, Rie Horii, Futoshi Akiyama,[...]. Radiology 2018
28
20

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).
Mehra Golshan, Constance T Cirrincione, William M Sikov, Donald A Berry, Sara Jasinski, Tracey F Weisberg, George Somlo, Clifford Hudis, Eric Winer, David W Ollila. Ann Surg 2015
112
16


Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.
Alberto Bouzón, Benigno Acea, Rafaela Soler, Ángela Iglesias, Paz Santiago, Joaquín Mosquera, Lourdes Calvo, Teresa Seoane-Pillado, Alejandra García. Radiol Oncol 2016
25
16

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.
Judy C Boughey, Linda M McCall, Karla V Ballman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Teresa Flippo-Morton, Kelly K Hunt. Ann Surg 2014
237
16

Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
Michael L Marinovich, Nehmat Houssami, Petra Macaskill, Francesco Sardanelli, Les Irwig, Eleftherios P Mamounas, Gunter von Minckwitz, Meagan E Brennan, Stefano Ciatto. J Natl Cancer Inst 2013
214
16


Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging.
A Fangberget, L B Nilsen, K H Hole, M M Holmen, O Engebraaten, B Naume, H-J Smith, D R Olsen, T Seierstad. Eur Radiol 2011
103
12

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
G Curigliano, H J Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, M Colleoni, M M Regan, M Piccart-Gebhart, H-J Senn,[...]. Ann Oncol 2017
619
12

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival.
Keith N Ogston, Iain D Miller, Simon Payne, Andrew W Hutcheon, Tarun K Sarkar, Ian Smith, A Schofield, Steven D Heys. Breast 2003
541
12


Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.
J A van der Hage, C J van de Velde, J P Julien, M Tubiana-Hulin, C Vandervelden, L Duchateau. J Clin Oncol 2001
750
12

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients.
Briete Goorts, Thiemo J A van Nijnatten, Linda de Munck, Martine Moossdorff, Esther M Heuts, Maaike de Boer, Marc B I Lobbes, Marjolein L Smidt. Breast Cancer Res Treat 2017
45
12

Preoperative chemotherapy for women with operable breast cancer.
J S D Mieog, J A van der Hage, C J H van de Velde. Cochrane Database Syst Rev 2007
245
12

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
12


MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
Kandace P McGuire, Jorge Toro-Burguete, Hang Dang, Jessica Young, Atilla Soran, Margarita Zuley, Rohit Bhargava, Marguerite Bonaventura, Ronald Johnson, Gretchen Ahrendt. Ann Surg Oncol 2011
82
12

Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer.
Eun Sook Ko, Boo-Kyung Han, Rock Bum Kim, Eun Young Ko, Jung Hee Shin, Soo Yeon Hahn, Seok Jin Nam, Jeong Eon Lee, Se Kyung Lee, Young-Hyuck Im,[...]. Ann Surg Oncol 2013
45
12

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim,[...]. N Engl J Med 2017
757
12

Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy.
Jiyoon Park, Eun Young Chae, Joo Hee Cha, Hee Jung Shin, Woo Jung Choi, Young-Wook Choi, Hak Hee Kim. Eur J Radiol 2018
23
13

Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?
C K Kuhl, P Mielcareck, S Klaschik, C Leutner, E Wardelmann, J Gieseke, H H Schild. Radiology 1999
889
12

Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer.
Gaiane M Rauch, Beatriz Elena Adrada, Henry Mark Kuerer, Raquel F D van la Parra, Jessica W T Leung, Wei Tse Yang. AJR Am J Roentgenol 2017
52
12


Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, R G Margolese, A B Cruz, E R Fisher, D L Wickerham, N Wolmark,[...]. J Clin Oncol 1997
12

Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients.
Annina Baumgartner, Christoph Tausch, Stefanie Hosch, Bärbel Papassotiropoulos, Zsuzsanna Varga, Christoph Rageth, Astrid Baege. Breast 2018
29
12

Role of MRI to Assess Response to Neoadjuvant Therapy for Breast Cancer.
Beatriu Reig, Laura Heacock, Alana Lewin, Nariya Cho, Linda Moy. J Magn Reson Imaging 2020
19
15

Breast MRI: State of the Art.
Ritse M Mann, Nariya Cho, Linda Moy. Radiology 2019
206
12

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
12


Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
Priya Rastogi, Stewart J Anderson, Harry D Bear, Charles E Geyer, Morton S Kahlenberg, André Robidoux, Richard G Margolese, James L Hoehn, Victor G Vogel, Shaker R Dakhil,[...]. J Clin Oncol 2008
8

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
Chafika Mazouni, Florentia Peintinger, Shu Wan-Kau, Fabrice Andre, Ana M Gonzalez-Angulo, W Fraser Symmans, Funda Meric-Bernstam, Vicente Valero, Gabriel N Hortobagyi, Lajos Pusztai. J Clin Oncol 2007
192
8


Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Xia Li, Richard G Abramson, Lori R Arlinghaus, Hakmook Kang, Anuradha Bapsi Chakravarthy, Vandana G Abramson, Jaime Farley, Ingrid A Mayer, Mark C Kelley, Ingrid M Meszoely,[...]. Invest Radiol 2015
101
8

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
Martin D Pickles, Martin Lowry, David J Manton, Peter Gibbs, Lindsay W Turnbull. Breast Cancer Res Treat 2005
147
8



Neoadjuvant chemotherapy with MRI monitoring for breast cancer.
R V Dave, R Millican-Slater, D Dodwell, K Horgan, N Sharma. Br J Surg 2017
16
12

Role of imaging in neoadjuvant therapy for breast cancer.
Vandana Dialani, Tamuna Chadashvili, Priscilla J Slanetz. Ann Surg Oncol 2015
66
8

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
M Kaufmann, G von Minckwitz, H D Bear, A Buzdar, P McGale, H Bonnefoi, M Colleoni, C Denkert, W Eiermann, R Jackesz,[...]. Ann Oncol 2007
272
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.